Crystal Structure of the Human Carboxypeptidase N (Kininase I) Catalytic Domain

Journal of Molecular Biology

Volumn 366, Issue 2, 2007, Pages 504-516

  Keil, Cora ^a   Maskos, Klaus ^a,b   Than, Manuel ^a,c   Hoopes, J Todd ^a   Huber, Robert ^a   Tan, Fulong ^d   Deddish, Peter A ^d   Erdös, Ervin G ^d   Skidgel, Randal A ^d   Bode, Wolfram ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b PROTEROS BIOSTRUCTURES GMBH   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

carboxypeptidase; hormone processing; peptide modification; transthyretin like domain; zinc peptidase

Indexed keywords

ARGININE; ARGININE CARBOXYPEPTIDASE; BRADYKININ; GLUCOSAMINE; PEPTIDE HORMONE; PHENYLALANINE; PREALBUMIN; PROLINE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CRYSTAL STRUCTURE; DNA FLANKING REGION; ENZYME ACTIVE SITE; HORMONE SYNTHESIS; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MODIFICATION;

PYRUS;

EID: 33846448485     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.11.025     Document Type: Article

References (57)

1. Skidgel R.A. Structure and function of mammalian zinc carboxypeptidases. In: Hooper N.M. (Ed). Zinc Metalloproteases in Health and Disease (1996), Taylor and Francis Ltd, London 241-283
2. Fricker L.D., and Leiter E.H. Peptides, enzymes and obesity: new insights from a 'dead' enzyme. Trends Biochem. Sci. 24 (1999) 390-393
3. Vendrell J., Querol E., and Aviles F.X. Metallocarboxypeptidases and their protein inhibitors. Structure, function and biomedical properties. Biochim. Biophys. Acta 1477 (2000) 284-298
4. Erdös E.G., and Sloane E.M. An enzyme in human blood plasma that inactivates bradykinin and kallidins. Biochem. Pharmacol. 11 (1962) 582-592
5. Skidgel R.A., and Erdös E.G. Lysine carboxypeptidase. In: Barrett A.J., Rawlings N.D., and Woessner J.F. (Eds). Handbook of Proteolytic Enzymes. 2nd edit. (2004), Academic Press, London 837-840
6. Bokisch V.A., and Müller-Eberhard H.J. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J. Clin. Invest. 49 (1970) 2427-2436
7. Ember J.A., and Hugli T.E. Complement factors and their receptors. Immunopharmacology 38 (1997) 3-15
8. Skidgel R.A., Johnson A.R., and Erdös E.G. Hydrolysis of opioid hexapeptides by carboxypeptidase N. Presence of carboxypeptidase in cell membranes. Biochem. Pharmacol. 33 (1984) 3471-3478
9. Magnan J., Paterson S.J., and Kosterlitz H.W. The interaction of [MET5]enkephalin and [LEU5]enkephalin sequences, extended at the C-terminus, with the mu-, delta- and kappa-binding sites in the guinea-pig brain. Life Sci. 31 (1982) 1359-1361
10. Leeb-Lundberg L.M., Marceau F., Muller-Esterl W., Pettibone D.J., and Zuraw B.L. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57 (2005) 27-77
11. De La Luz Sierra M., Yang F., Narazaki M., Salvucci O., Davis D., Yarchoan R., et al. Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood 103 (2004) 2452-2459
12. Davis D.A., Singer K.E., De La Luz Sierra M., Narazaki M., Yang F., Fales H.M., et al. Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation. Blood 105 (2005) 4561-4568
13. McGwire G.B., and Skidgel R.A. Extracellular conversion of epidermal growth factor (EGF) to des-Arg53-EGF by carboxypeptidase M. J. Biol. Chem. 270 (1995) 17154-17158
14. Puleo P.R., Meyer D., Wathen C., Tawa C.B., Wheeler S., Hamburg R.J., et al. Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N. Engl. J. Med. 331 (1994) 561-566
15. Erdös E.G., and Skidgel R.A. More on subforms of creatine kinase MB. N. Engl. J. Med. 333 (1995) 390
16. Plow E.F., Allampallam K., and Redlitz A. The plasma carboxypeptidases and the regulation of the plasminogen system. Trends Cardiovasc. Med. 7 (1997) 71-75
17. Oshima G., Kato J., and Erdös E.G. Subunits of human plasma carboxypeptidase N (kininase I; anaphylatoxin inactivator). Biochim. Biophys. Acta 365 (1974) 344-348
18. Oshima G., Kato J., and Erdös E.G. Plasma carboxypeptidase N, subunits and characteristics. Arch. Biochem. Biophys. 170 (1975) 132-138
19. Plummer T.H.J., and Hurwitz M.Y. Human plasma carboxypeptidase N. Isolation and characterization. J. Biol. Chem. 253 (1978) 3907-3912
20. Levin Y., Skidgel R.A., and Erdös E.G. Isolation and characterization of the subunits of human plasma carboxypeptidase N (kininase I). Proc. Natl Acad. Sci. USA 79 (1982) 4618-4622
21. Kobe B., and Kajava A.V. The leucine-rich repeat as a protein recognition motif. Curr. Opin. Struct. Biol. 11 (2001) 725-732
22. Tan F., Weerasinghe D.K., Skidgel R.A., Tamei H., Kaul R.K., Roninson I.B., et al. The deduced protein sequence of the human carboxypeptidase N high molecular weight subunit reveals the presence of leucine-rich tandem repeats [published erratum appears in]. J. Biol. Chem. 265 (1990) 13-19
23. Quagraine M.O., Tan F., Tamei H., Erdös E.G., and Skidgel R.A. Plasmin alters the activity and quaternary structure of human plasma carboxypeptidase N. Biochem. J. 388 (2005) 81-91
24. Skidgel R.A. Human carboxypeptidase N: lysine carboxypeptidase. Methods Enzymol. 248 (1995) 653-663
25. Grimwood B.G., Plummer Jr. T.H., and Tarentino A.L. Characterization of the carboxypeptidase N secreted by Hep G2 cells. J. Biol. Chem. 263 (1988) 14397-14401
26. Aloy P., Companys V., Vendrell J., Aviles F.X., Fricker L.D., Coll M., and Gomis-Ruth F.X. The crystal structure of the inhibitor-complexed carboxypeptidase D domain II and the modeling of regulatory carboxypeptidases. J. Biol. Chem. 276 (2001) 16177-16184
27. Gomis-Rüth F.X., Companys V., Quian Q., Fricker L.D., Vendrell J., Aviles F.X., and Coll M. Crystal structure of avian carboxypeptidase D domain II: a prototype for the regulatory metallocarboxypeptidase subfamily. EMBO J. 21 (1999) 5817-5826
28. Reverter D., Maskos K., Tan F., Skidgel R.A., and Bode W. Crystal structure of human carboxypeptidase M, a membrane-bound enzyme that regulates peptide hormone activity. J. Mol. Biol. 338 (2004) 257-269
29. Rees D.C., Lewis M., and Lipscomb W.N. Refined crystal structure of carboxypeptidase A at 1.54 Å resolution. J. Mol. Biol. 168 (1983) 367-387
30. Peter-Katalinic J. MO-glycosylation of proteins. IEnzymes Enzymol 405 (2005) 139-171
31. Christlet T.H., and Veluraja K. Database analysis of O-glycosylation sites in proteins. Biophys. J. 80 (2001) 952-960
32. Rees D.C., and Lipscomb W.N. Refined crystal structure of the potato inhibitor complex of carboxypeptidase A at 2.5 Å resolution. J. Mol. Biol. 160 (1982) 475-498
33. Reverter D., Fernandez-Catalan C., Baumgartner R., Pfänder R., Huber R., Bode W., et al. Structure of a novel leech carboxypeptidase inhibitor determined free in solution and in complex with human carboxypeptidase A2. Nature Struct. Biol. 7 (2000) 322-328
34. Pallares I., Bonet R., Garcia-Castellanos R., Ventura S., Aviles F.X., Vendrell J., and Gomis-Rüth F.X. Structure of human carboxypeptidase A4 with its endogenous protein inhibitor, latexin. Proc. Natl Acad. Sci. USA 102 (2005) 3978-3983
35. Aagaard A., Listwan P., Cowieson N., Huber T., Ravasi T., Wells C.A., et al. An inflammatory role for the mammalian carboxypeptidase inhibitor latexin: relationship to cystatins and the tumor suppressor TIG1. Structure 13 (2005) 309-317
36. Arolas J.L., Popowicz G.M., Lorenzo J., Sommerhoff C.P., Huber R., Aviles F.X., and Holak T.A. The three-dimensional structures of tick carboxypeptidase inhibitor in complex with A/B carboxypeptidases reveal a novel double-headed binding mode. J. Mol. Biol. 350 (2005) 489-498
37. Redlitz A., Tan A.K., Eaton D.L., and Plow E.F. Plasma carboxypeptidases as regulators of the plasminogen system. J. Clin. Invest. 96 (1995) 2534-2538
38. Novikova E.G., Eng F.J., Yan L., Qian Y., and Fricker L.D. Characterization of the enzymatic properties of the first and second domains of metallocarboxypeptidase D. J Biol Chem. 274 (1999) 28887-28892
39. Grimwood B.G., Plummer Jr. T.H., and Tarentino A.L. Carboxypeptidase H. A regulatory peptide-processing enzyme produced by human hepatoma Hep G2 cells. J. Biol. Chem. 264 (1989) 15662-15667
40. Skidgel R.A., and Erdös E.G. Cellular carboxypeptidases. Immunol. Rev. 161 (1998) 129-141
41. Skidgel R.A., Davis R.M., and Tan F. Human carboxypeptidase M. Purification and characterization of a membrane-bound carboxypeptidase that cleaves peptide hormones. J. Biol. Chem. 264 (1989) 2236-2241
42. McKay T.J., Phelan A.W., and Plummer Jr. T.H. Comparative studies on human carboxypeptidases B and N. Arch. Biochem. Biophys. 197 (1979) 487-492
43. Skidgel R.A., Kawahara M.S., and Hugli T.E. Functional significance of the subunits of carboxypeptidase N (kininase I). Adv. Exp. Med. Biol. 198 (1986) 375-380
44. Christianson D.W., and Lipscomb W.N. Carboxypeptidase A. Acc. Chem. Res. 22 (1989) 62-69
45. Garcia-Saez I., Reverter D., Vendrell J., Avilés F.X., and Coll M. The three-dimensional structure of human procarboxypeptidase A2. Deciphering the basis of its inhibition, activation and intrinsic activity of the zymogen. EMBO J. 23 (1997) 6906-6913
46. Lipscomb W.N., and Sträter N. Recent advances in zinc enzymology. Chem. Rev. 96 (1996) 2375-2434
47. Jones D.T. Protein secondary structure prediction based on position-specific scoring matrices. J. Mol. Biol. 292 (1999) 195-202
48. Kobe B., and Deisenhofer J. Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature 366 (1993) 751-756
49. Papageorgiou A.C., Shapiro R., and Acharya K.R. Molecular recognition of human angiogenin by placental ribonuclease inhibitor-an X-ray crystallographic study at 2.0 Å resolution. EMBO J. 16 (1997) 5162-5177
50. Tan F., Deddish P.A., and Skidgel R.A. Human carboxypeptidase M. Methods Enzymol 248 (1995) 663-675
51. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
52. Collaborative Computational Project No. 4. The CCP4 suite: programs for protein crystallography. Acta Crystallog. sect. D 50 (1994) 760-763
53. Jones T.A., Zou J.Y., and Cowan S.W. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallog. sect. A 47 (1991) 110-117
54. D. Turk, (1992). Weiterenentwicklung eines Programmes für Molekülgrafik und Electronendichte-Manipulation und seine Anwendung auf verschiedene Protein-Struktur-Aufklärungen. PhD thesis, Technische Universität, München.
55. Brünger A.T., Adams P.D., Clore G.M., Delano W.L., Gross P., Grossekunstleve R.W., et al. Crystallography and NMR System - a new software suite for macromolecular and structure determination. Acta Crystallog. sect. D 54 (1998) 905-921
56. Higgins D., Thompson J., Gibson T., Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl. Acids Res. 22 (1994) 4673-4680
57. Nichols A.R., Sharp K., and Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins: Struct. Funct. Genet. 11 (1991) 281-296